Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,45 € ↓ -0,04 (-8,23%)
2026-06-05
DEL PRIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionBridgeway Capital Management Inc
Latest Disclosed Ownership75,758 shares
Latest Disclosed Value $ 79,546
Bridgeway Capital Management Inc ownership in CYX / Cardlytics, Inc.

On May 15, 2026 - Bridgeway Capital Management Inc filed a 13F-HR form disclosing ownership of 75,758 shares of Cardlytics, Inc. (DE:CYX) valued at $56,106 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 75,758 shares of Cardlytics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $33,788 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CARDLYTICS COM 14161W105 75,758 0 0.00 80 -9.20 0.0016
2026-02-17 2025-12-31 13F CARDLYTICS COM 14161W105 75,758 -26,242 -25.73 87 -64.78 0.0018
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 102,000 50,000 96.15 248 190.59 0.0053
2025-08-14 2025-06-30 13F CARDLYTICS COM 14161W105 52,000 0 0.00 86 -9.57 0.0020
2025-05-15 2025-03-31 13F CARDLYTICS COM 14161W105 52,000 -60,000 -53.57 95 -77.35 0.0024
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 112,000 112,000 416 0.0093
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 0 -42,158 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 42,158 -15,000 -26.24 611 15.97 0.0125
2024-02-14 2023-12-31 13F CARDLYTICS COM 14161W105 57,158 -15,842 -21.70 526 -56.31 0.0113
2023-11-14 2023-09-30 13F CARDLYTICS COM 14161W105 73,000 0 0.00 1,204 161.17 0.0292
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 73,000 73,000 461 0.0110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.